Stem Cell Agency, CIRM, files $5.5 billion ballot measure proposal for Nov. 2020 election

We have reported extensively on the work of the California Stem Cell Agency, officially known as the California Institute for Regenerative Medicine (CIRM), and the conclusion of their initial $3 billion in funding distribution. And now, the official word is that the agency has submitted the required paperwork to try and qualify a ballot measure in the Nov. 2020 elections to generate $5.5 billion in bonds to refinance the agency. The measure now needs to gather over 633,000 valid signatures to qualify for the official ballot.

The complex, 30-page initiative would also restructure a number of aspects of the agency and provide for financial assistance for patients and their families who might be involved in clinical trials. The $3 billion agency expects to run out of cash for new awards at the end of this month.

There are significant changes that have been incorporated in this proposal worth scrutinizing. In addition to stem cell research, the proposed initiative would provide for awards for other “vital research” opportunities. Training for professionals would be emphasized. The governing board of the agency would be increased from 29 to 35 persons. Representatives of the California State University system would have a greater official role in addition to representatives from the University of California. Additional changes are proposed in priorities along with alteration in conflict of interest rules and its public records provisions. You can read the entire document HERE.

Members of the general public may submit comments about the proposed measure to the California Attorney General HERE.

Previous
Previous

AXIS Dance launches home season with in•ter•twine Oct. 25-27

Next
Next

Filmmakers seeking funding for Daruma, featuring cast members with disabilities